As a Senior Financial Analyst, I serve as finance partner to marketing and strategy teams, managing an annual expense budget of $24 million dollars. I provide spending analysis, cost-savings recommendations, and product investment modeling for 10-year strategic plans. Previously, I specialized in risk assessment and financial consolidations within FP&A for the ENT business. I partnered with the divisional CFO and international finance leaders to consolidate revenue, P&L, and cash flow scenarios. I am currently pursuing an MBA at the Zicklin School of Business, focusing on data driven analytics, corporate strategy, dynamic of competition, and operations. I hope to apply these skills in business partnering, strategic investment decision making, and financial analysis to support the advancement of medical products.Prior to my current role, I was part of the Neuroscience Controllership team where I collaborated with legal and R&D to manage Medtronic's Neuroscience portfolio royalties. I prepared journal entries amounting to $15M a quarter in payables. Additionally, I led the process of standardizing the method used to raise sensitive information and created a payment tracker for legal and finance stakeholders.